{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T22:47:09Z","timestamp":1795214829951,"version":"4.10.3"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as an obesity-driven condition, with excess adiposity serving both as a risk factor and a defining comorbidity. Paradoxically, once HFpEF is established, higher body mass index (BMI) is often associated with improved survival, a phenomenon termed the \u201cobesity paradox.\u201d Epidemiological studies, including analyses of the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial and large registries, show that overweight and obese HFpEF patients experience lower all-cause mortality compared with normal-weight counterparts, while underweight patients face the worst prognosis due to frailty and cachexia. The survival benefit, however, appears to be shaped by factors beyond BMI. Evidence suggests that favorable body composition, particularly greater lean mass and metabolic reserve, underlies much of the observed advantage. Cardiorespiratory fitness further modifies outcomes, with \u201cfat but fit\u201d individuals driving much of the paradox, while sarcopenic obesity portends poor survival. Inflammatory signaling and adipokine patterns also contribute, with differences in leptin, adiponectin, and cytokine profiles potentially buffering obese patients from catabolic stress. Importantly, fat distribution is critical: visceral and epicardial fat confer risk, whereas subcutaneous fat may be relatively benign, challenging the validity of BMI as a prognostic marker. Critics highlight confounding from cachexia-related weight loss, lead-time bias, and BMI\u2019s inability to distinguish fat from muscle. Emerging therapies, including glucagon-like peptide-1 receptor agonists and structured exercise regimens, demonstrate that intentional, controlled weight loss, especially targeting visceral fat while preserving lean mass, can improve symptoms, function, and quality of life. Ultimately, the obesity paradox underscores the need for nuanced, phenotype-specific management rather than complacency toward obesity in HFpEF.<\/jats:p>","DOI":"10.1097\/crd.0000000000001106","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:01:48Z","timestamp":1762480908000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Obesity Paradox in Heart Failure With Preserved Ejection Fraction: Untangling Body Composition, Inflammation, and Outcomes"],"prefix":"10.1097","author":[{"given":"Lana","family":"Tannous","sequence":"first","affiliation":[{"name":"New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Tated","sequence":"additional","affiliation":[{"name":"Department of Public Health, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishkar","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texila American University, Georgetown, Guyana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruvi K.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Narendra Modi Medical College and Sheth L.G. Hospital, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth P.","family":"Agrawal","sequence":"additional","affiliation":[{"name":"New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"R1-20251130","doi-asserted-by":"crossref","first-page":"e0323634","DOI":"10.1371\/journal.pone.0323634","article-title":"Association of predicted lean body mass and fat mass with prognosis in patients with heart failure preserved ejection fraction.","volume":"20","author":"Su","year":"2025","journal-title":"PLoS One"},{"key":"R2-20251130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ejhf.1956","article-title":"Regional adiposity and heart failure with preserved ejection fraction.","volume":"22","author":"Rao","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R4-20251130","doi-asserted-by":"crossref","first-page":"966745","DOI":"10.3389\/fcvm.2022.966745","article-title":"Associations of body mass index with mortality in heart failure with preserved ejection fraction patients with ischemic versus non-ischemic etiology.","volume":"9","author":"Zeng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R5-20251130","doi-asserted-by":"crossref","first-page":"743327","DOI":"10.3389\/fcvm.2021.743327","article-title":"The \"Obesity Paradox\" in patients with HFpEF with or without comorbid atrial fibrillation.","volume":"8","author":"Guo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R6-20251130","doi-asserted-by":"crossref","first-page":"e035430","DOI":"10.1161\/JAHA.124.035430","article-title":"Novel adiposity indices are associated with poor prognosis in heart failure with preserved ejection fraction without the obesity paradox.","volume":"13","author":"Zhang","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R7-20251130","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s40519-020-00982-9","article-title":"Obesity paradox and heart failure.","volume":"26","author":"Donataccio","year":"2021","journal-title":"Eat Weight Disord"},{"key":"R8-20251130","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2017.09.1111","article-title":"Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF.","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"JACC"},{"key":"R9-20251130","doi-asserted-by":"crossref","first-page":"821829","DOI":"10.3389\/fcvm.2022.821829","article-title":"\u201cObesity\u2013years\u201d burden may predict reversibility in heart failure with preserved ejection fraction.","volume":"9","author":"Chockalingam","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R10-20251130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.36628\/ijhf.2022.0007","article-title":"Body mass index, muscle mass, and all-cause mortality in patients with acute heart failure: the obesity paradox revisited.","volume":"4","author":"Hwang","year":"2022","journal-title":"Int J Heart Fail"},{"key":"R11-20251130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pcad.2013.09.006","article-title":"Contribution of cardiorespiratory fitness to the obesity paradox.","volume":"56","author":"McAuley","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"R12-20251130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11897-024-00690-w","article-title":"Obesity, metabolic syndrome, and obesity paradox in heart failure: a critical evaluation.","volume":"22","author":"Catalfamo","year":"2024","journal-title":"Curr Heart Fail Rep"},{"key":"R13-20251130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12872-025-04998-w","article-title":"Body mass index, exercise capacity and functional status in chronic heart failure.","volume":"25","author":"Noumegni","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"R14-20251130","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/diagnostics14232677","article-title":"Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review.","volume":"14","author":"Theodorakis","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"R15-20251130","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment.","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R16-20251130","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurjpc\/zwaa139","article-title":"Sarcopenia in heart failure: \u2018waste\u2019 the appropriate time and resources, not the muscles.","volume":"28","author":"Kokkinidis","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R17-20251130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12877-022-03168-3","article-title":"Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF.","volume":"22","author":"Saito","year":"2022","journal-title":"BMC Geriatr"},{"key":"R18-20251130","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial.","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"R19-20251130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","article-title":"Obesity and the obesity paradox in heart failure.","volume":"61","author":"Horwich","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"R20-20251130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.123.067505","article-title":"Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial.","volume":"149","author":"Kosiborod","year":"2024","journal-title":"Circulation"},{"key":"R21-20251130","first-page":"06481","article-title":"2025 ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of Cardiology.","volume":"S0735-1097","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R22-20251130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2023.02.012","article-title":"Supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the American Heart Association and American College of Cardiology.","volume":"81","author":"Sachdev","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:00:22Z","timestamp":1764478822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001106","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}